Effect of body composition parameters, including sarcopenia, myosteatosis, and adipose tissue, on overall survival of patients with mCRPC receiving 177Lu-PSMA PRRT
Sarcopenia and myosteatosis before treatment were associated with shorter survival in mCRPC patients who were scheduled for Lu-177 PSMA treatment. Patients with left psoas myosteatosis value ≤26.85 HU had shorter OS, and we showed that OS is an independent prognostic factor.
Authors
- Mehmet Serdar Yıldırım (ORCID: https://orcid.org/0000-0001-9422-1346)
- Raşit Kılıç (ORCID: https://orcid.org/0000-0001-6671-9067)
- İhsan Kaplan (ORCID: https://orcid.org/0000-0002-5727-4702)
- Ferat Kepenek (ORCID: https://orcid.org/0000-0002-5631-7643)
- Hüseyin Karaoğlan
- Fatih Güzel (ORCID: https://orcid.org/0000-0002-8571-3418)
- Ayhan Şenol (ORCID: https://orcid.org/0000-0001-5467-0307)
- Halil Kömek (ORCID: https://orcid.org/0000-0001-8168-136X)
- Bilgin Bahadır Başgöz (ORCID: https://orcid.org/0000-0002-5795-533X)
- Yunus Güzel (ORCID: https://orcid.org/0000-0002-8555-0460)
- Veysi Şenses (ORCID: https://orcid.org/0009-0002-0529-9278)
- Ömer Yeprem
- Fulya Kaya İpek (ORCID: https://orcid.org/0009-0005-4303-4993)
Institutions
- Diyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi (TR)
Publication Details
- Journal
- Nuclear Medicine Communications
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1097/mnm.0000000000001985
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00